Penile cancer begins in the penis and includes various types such as: basal cell penile cancer, melanoma, sarcoma, and epidermoid/squamous cell carcinoma. Squamous cell carcinoma is the most common form of penile cancer. Penile cancer is a relatively uncommon cancer as it only accounts for 10% of all male cancers. Risk factors for developing penile cancer include exposure and infection from the human papillomavirus (HPV), age, smoking, phimosis, an HIV/Aids infection, and poor personal hygiene. Treatment for penile cancer includes surgery, laser therapy, radiation therapy, chemotherapy, and supportive/palliative care. Metastatic penile cancer occurs when the cancer has spread to various locations in the body. When this occurs, the cancer generally becomes incurable--treatments tend to focus on alleviating pain and symptoms rather than attacking the cancer itself.
Metastatic Penile Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Metastatic Penile Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 341 products for the study of Metastatic Penile Cancer that can be applied to Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.